A breakthrough zwitterionic polymer slips through the skin’s toughest barriers, carrying insulin deep into tissue and normalizing blood sugar, offering patients a painless alternative to daily injections.
A recent study published in the journal Nature examines the use of the skin-permeable molecule poly[2-(N-oxide-N,N-dimethylamino)ethyl methacrylate] (OP) as a delivery system for insulin, a key drug in the treatment of type 1 and many cases of type 2 diabetes mellitus.
Small-molecule drugs are often designed to be absorbed through the skin. However, this has not been found feasible for large biomolecules, such as proteins and peptides like insulin.
Barriers to insulin delivery
Insulin is typically administered by intradermal injection. This method is painful, can induce fear of needles, and skin complications, all of which are linked to poor patient compliance. No successful noninvasive technique of insulin delivery has yet been reported.
Transdermal drug delivery offers several advantages, including improved patient compliance, convenience, increased active drug concentration by avoiding denaturation, and reduced first-pass metabolism of the drug. Among the greatest challenges in this approach is getting past the stratum corneum (SC) of the skin.
The SC is composed of dead and dried-out corneocytes surrounded by a well-ordered fatty matrix. Along with the epithelial tight junctions in the epidermis and dermis, this presents a barrier to drug penetration. Potential approaches include chemical penetration enhancers, electrically-driven devices that force the drug to penetrate the skin, and injection by ultrasound or jet rather than hypodermic needles, as well as microneedles. Being invasive, these are, however, associated with a higher risk of infection.
Cationic peptides can sometimes pass through the skin, bound to organic acids in the sebum and stratum corneum. However, this binding immobilizes them in the SC, preventing their deeper diffusion. Their only route lies through the hair follicles and sweat glands, comprising <0.1 % of skin area, meaning penetration is inefficient.
This prompted the current exploration of the novel polymer OP. The extreme skin permeability of OP-I does not involve any change in skin lipid ordering or structure. Instead, molecular dynamics simulations revealed that OP-I was adsorbed by stratum corneum fats faster than native insulin, diffusing rapidly through the lipids to reach the dermis and subcutaneous tissue.
This was characterized by a transition from its protonated cationic state (at a pH of 5 or lower) to a zwitterion during its skin passage (at neutral pH). This pH-dependent charge shift aligns with the skin’s acidic-to-neutral gradient and is central to OP’s transport behavior.
OP can thus pass quickly and smoothly through the skin into the blood and lymph vessels. OP and OP–insulin primarily enter systemic circulation through leaky lymphatic capillaries before reaching the bloodstream.
Study findings
OP diffusion
The researchers applied fluorescent-labeled OP to the skin surface of mice and minipigs (the skin of the latter being very similar to human skin) and tracked its passage through the skin using high-resolution imaging.
In mice, OP diffused throughout all skin layers within four hours of topical application, whereas the control polyethylene glycol (PEG) remained on the skin surface. In the epidermis and dermis, OP-I moved by membrane-mediated diffusion without entering the cell. This involved rapid “hopping” along adjacent cell membranes rather than intracellular transport.
Further confirmation was obtained by visualizing the OP-bound gold nanoparticles within the lipid lamellae of the intercorneocyte fatty layer. OP penetrates the skin with exceptional efficiency, entering the bloodstream within 30 minutes. Its concentration peaked approximately two hours later.
Insulin-conjugated OP
Recombinant human insulin was then conjugated to OP (OP-I), with pegylated insulin serving as a control, having a similar molecular mass of 5 kDa. OP-I had the same secondary structure as insulin. It also showed unchanged receptor binding and association-dissociation constants, indicating that it retained the receptor specificity and affinity of native insulin intact.
OP-I skin permeability was measured by the drop in blood glucose following topical application. When compared with unbound insulin, the conjugated insulin produced the same decrease in blood glucose.
Thus, the study suggests that OP-I behaves similarly to insulin, binding to the insulin receptor with unchanged specificity and activating downstream pathways that result in glucose-lowering effects. OP-I had a longer half-life than insulin, probably because of its zwitterionic nature that resists plasma protein binding and removal from the blood. This extension was modest (15 to 20 minutes vs. 5 to 10 minutes for native insulin).
Modeling of the skin permeation of OP-I over time using confocal laser-scanning microscopy (CLSM) showed its uniform spread throughout the epidermis in half an hour. In contrast, native insulin and PEG-I remained on the skin surface. Thus, OP-I had the highest permeability coefficient among the three, approximately 4.5 and 9-fold that of the PEG-I and insulin, respectively.
OP effects on insulin and blood glucose
OP-I achieved comparable plasma levels to subcutaneous insulin within two hours. After this point, its levels were 60 % to 600 % higher than with insulin. The other two molecules did not affect blood insulin levels.
In mice with type 1 diabetes, OP-I normalized blood glucose levels. Once in the blood, OP-I was taken up mainly by the liver, lungs and kidneys, inducing insulin activity. Its activity was prolonged compared to subcutaneous native insulin, which was rapidly cleared from the bloodstream without significant accumulation in these tissues. OP-I regulated blood glucose levels better in diabetic mice than other treatments.
Similar findings were observed in minipigs, with OP-I entering the dermis and subcutaneous tissue at four hours following topical application. It induced normal blood glucose levels within two hours and maintained them for 12 hours.
Notably, topical OP-I application did not irritate the skin or induce inflammation. Repeated application in both mice and minipigs caused no structural changes to the stratum corneum or signs of immune activation.
Toward needle-free insulin
The skin-permeable polymer may enable non-invasive transdermal delivery of insulin, relieving patients with diabetes from subcutaneous injections and potentially facilitating patient-friendly use of other protein- and peptide-based therapeutics through transdermal delivery.
- Wei, Q., He, Z., Zhou, Z., et al. (2025). A skin-permeable polymer for non-invasive transdermal insulin delivery. Nature. doi: https://doi.org/10.1038/s41586-025-09729-x. https://www.nature.com/articles/s41586-025-09729-x
News
Building the Brain Requires Millions of Dangerous DNA Breaks
Scientists discovered that building a healthy brain involves an unexpected step: young neurons routinely break and rapidly repair their own DNA. As the brain develops, newly formed nerve cells must travel through tightly packed tissue [...]
One Tiny Change May Explain How Viruses Jump From Bats to Humans
Scientists found that one tiny genetic change may determine whether a bat virus stays in bats or becomes a human threat. Most infectious disease outbreaks begin when a virus or other pathogen crosses from animals into [...]
Scientists Discover 250+ Genes That Could Lead to New Ways To Prevent Melanoma
The world’s largest study of mole genetics identified hundreds of genes tied to melanoma risk, uncovering potential new drug targets and paving the way for more accurate melanoma screening and prevention. Researchers at QIMR [...]
Breakthrough Diabetes Treatment Reprograms the Immune System
An engineered stem cell therapy reversed new-onset Type 1 diabetes in mice by shifting the immune system away from attacking insulin-producing cells. For more than a century, people with Type 1 diabetes have relied [...]
Taking the world’s temperature: WHO chief spotlights global health emergencies
Taking the world’s temperature on pressing health matters, WHO Director-General Tedros Adhanom Ghebreyesus provided the latest on current global challenges - and successes when it comes to international cooperation. “The outbreaks of hantavirus, Ebola and Marburg all show [...]
Scientists Create Tiny “Mini Livers” That Could One Day Replace Liver Transplants
Engineered tissue grafts could help perform key liver functions and benefit thousands of people living with liver failure. The liver is one of the body’s hardest-working organs, carrying out hundreds of vital jobs, from [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
Scientists Discover Surprising Way To Help the Brain Recover After Stroke
A new study suggests that strengthening the body’s natural circadian rhythms may help the brain recover after stroke, even when treatment begins days after the injury. Every year, millions of people survive a stroke, [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Younger Generations Are Aging Faster – and It May Be Fueling a Surge in Cancer
Younger generations may be aging biologically faster than those before them, and that shift could help explain rising rates of cancer at younger ages. For decades, cancer was viewed largely as a disease of [...]
Using Cannabis Could Raise Your Stroke Risk by 37%, Massive Study Reveals
Large-scale evidence suggests cannabis, cocaine, and amphetamines may directly raise stroke risk, including in younger adults. As recreational drug use becomes increasingly common, researchers are uncovering evidence that its health consequences may extend far beyond [...]
Could Vitamin C Be the Secret to Keeping Your Brain Younger?
Lower vitamin C levels were linked to reduced brain volume and weaker neural connectivity in older adults, suggesting a potential connection between nutrition and brain health. Could a common vitamin help preserve the brain [...]
This Deadly Disease Was Wiping Out Humans 5,500 Years Ago
A new study suggests plague was already a deadly threat 5,500 years ago, striking small hunter-gatherer communities long before cities and agriculture emerged. For centuries, plague has been remembered as the disease that devastated [...]
China closing in but US leads in biotech quality, commercial reach, survey finds
SAN DIEGO, June 22 (Reuters) - China, which now conducts more clinical drug trials, opens new tab than the U.S., still lags in the quality and commercial reach of its biomedical science, according to a recent survey, opens new [...]
New method generates renewable supply of progenitor immune cells
In a paper published in Cell, a USC Stem Cell-led team reports a new way of generating a renewable and expandable supply of the progenitor cells that give rise to macrophages. These immune cells help [...]
Scientists Just Discovered a Cellular Survival System That Was Never Supposed To Exist
A surprising backup pathway allows cells to make a crucial amino acid when their primary machinery fails. For decades, biologists believed cells had only one way to access a molecule they cannot live without. New [...]
